Kari Chansky

Summary

Affiliation: Fred Hutchinson Cancer Research Center
Country: USA

Publications

  1. ncbi The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer
    Kari Chansky
    Statistics Department, Cancer Research and Biostatistics, Seattle, Washington 98101, USA
    J Thorac Oncol 4:792-801. 2009
  2. ncbi The IASLC Lung Cancer Staging Project: data elements for the prospective project
    Dorothy J Giroux
    Cancer Research and Biostatistics, Seattle, WA 98101, USA
    J Thorac Oncol 4:679-83. 2009
  3. ncbi Gefitinib therapy in advanced bronchioloalveolar carcinoma: Southwest Oncology Group Study S0126
    Howard L West
    Swedish Cancer Institute/Puget Sound Oncology Consortium, Seattle, WA, USA
    J Clin Oncol 24:1807-13. 2006
  4. ncbi Differences in toxicity between men and women treated with 5-fluorouracil therapy for colorectal carcinoma
    Kari Chansky
    Southwest Oncology Group Statistical Center, Seattle, Washington, USA
    Cancer 103:1165-71. 2005
  5. ncbi The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer
    Eric Vallieres
    Section of Thoracic and Foregut Surgery of the Swedish Cancer Institute, Seattle, Washington 98104, USA
    J Thorac Oncol 4:1049-59. 2009

Collaborators

Detail Information

Publications5

  1. ncbi The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer
    Kari Chansky
    Statistics Department, Cancer Research and Biostatistics, Seattle, Washington 98101, USA
    J Thorac Oncol 4:792-801. 2009
    ....
  2. ncbi The IASLC Lung Cancer Staging Project: data elements for the prospective project
    Dorothy J Giroux
    Cancer Research and Biostatistics, Seattle, WA 98101, USA
    J Thorac Oncol 4:679-83. 2009
    ..Successful collection and analysis of these data can be expected to yield unprecedented improvements in the utility and validity of lung cancer staging...
  3. ncbi Gefitinib therapy in advanced bronchioloalveolar carcinoma: Southwest Oncology Group Study S0126
    Howard L West
    Swedish Cancer Institute/Puget Sound Oncology Consortium, Seattle, WA, USA
    J Clin Oncol 24:1807-13. 2006
    ..003), never-smokers (P = .061), and patients with a PS of 0 or 1 (P = .015). CONCLUSION: Gefitinib is an active agent in advanced stage BAC. Several subsets demonstrate significantly improved clinical outcomes...
  4. ncbi Differences in toxicity between men and women treated with 5-fluorouracil therapy for colorectal carcinoma
    Kari Chansky
    Southwest Oncology Group Statistical Center, Seattle, Washington, USA
    Cancer 103:1165-71. 2005
    ..This process provided substantial evidence for gender differences in specific aspects of 5-FU toxicity that persist across a range of treatment regimens, patient characteristics, and cancer trial settings...
  5. ncbi The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer
    Eric Vallieres
    Section of Thoracic and Foregut Surgery of the Swedish Cancer Institute, Seattle, Washington 98104, USA
    J Thorac Oncol 4:1049-59. 2009
    ..This analysis was undertaken to examine the impact of the TNM system on the pathologic staging of SCLC and to assess the new IASLC proposals in this subtype of lung cancer...